IDA blend vs Latvia: Cause of death, by non-communicable diseases, ages 0-4, female
IDA blend
7.2%
in 2021
Latvia
40.7%
in 2021
IDA blend rank
40th
Latvia rank
41st
Cause of death, by non-communicable diseases, ages 0-4, female over time
- IDA blend
- Latvia
How they compare
Latvia currently reports 40.7% against 7.2% in IDA blend, a difference of 33.5%.
That makes Latvia's figure about 5.6 times IDA blend's.
Across all 6 years both countries report, Latvia has been ahead every year.
IDA blend ranks 40th and Latvia ranks 41st of 47 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1% | 42.5% | 38.3% | Latvia |
| 2010s | 6.3% | 36.7% | 30.5% | Latvia |
| 2020s | 7.1% | 36.8% | 29.6% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, IDA blend or Latvia?
- Latvia, at 40.7% against 7.2% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between IDA blend and Latvia?
- 33.5%, with Latvia ahead.
- How many years of comparable data are there for IDA blend and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Latvia rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- IDA blend ranks 40th and Latvia ranks 41st of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.